From the Departments of Nuclear Medicine.
Oncology, Penang Adventist Hospital, George Town, Penang, Malaysia.
Clin Nucl Med. 2019 Oct;44(10):808-809. doi: 10.1097/RLU.0000000000002739.
Extramammary Paget's disease (EMPD) is a rare disease with an estimated prevalence of 0.1 to 2.4 per 1,000,000 person-years. Metastatic EMPD has a poor prognosis with a 5-year survival of approximately 7%. Local therapy is the only curative option with surgery being recommended for resectable disease. It is therefore crucial to be able to stage such patients appropriately. The utility of F-FDG PET/CT for this disease is not well established. We share a case on how F-FDG PET/CT was used to stage metastatic EMPD.
乳房外帕哲氏病（EMPD）是一种罕见疾病，估计每 100 万人中有 0.1 至 2.4 人患病。转移性 EMPD 预后较差，5 年生存率约为 7%。局部治疗是唯一的治愈方法，对于可切除的疾病，建议手术治疗。因此，能够对这些患者进行适当的分期至关重要。18F-FDG PET/CT 在该疾病中的应用尚未得到充分证实。我们分享了一个使用 18F-FDG PET/CT 对转移性 EMPD 进行分期的病例。
